VYNE - VYNE Therapeutics Inc. (VYNE) CEO Dave Domzalski on Q3 2021 results - Earnings Call Transcript
VYNE Therapeutics Inc. (VYNE) Q3 2021 Earnings Conference Call November 10, 2021, 08:30 AM ET Company Participants John Fraunces – LifeSci Advisors Dave Domzalski – President and Chief Executive Officer Tyler Zeronda – Chief Financiial Officer Iain Stuart – Chief Scientific Officer Conference Call Participants David Amsellem – Piper Sandler Carvey Leung – Cantor Fitzgerald Patrick Dolezal – LifeSci Capital Presentation Operator Good morning and welcome to the VYNE Therapeutics conference call to discuss the Third Quarter 2021 financial results and corporate update. At this time, all participants are on listen-only mode. And following the Company's formal remarks, we will open the call for your questions. Please be advised that this call is being recorded at the Company's request. I will now turn the call over to John Fraunces of LifeSci Advisors. Please go ahead. John Fraunces Good morning, everyone and thank you for joining us. Participating in this morning's
For further details see:
VYNE Therapeutics Inc. (VYNE) CEO Dave Domzalski on Q3 2021 results - Earnings Call Transcript